Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 10Plasma cell 2Other hematologic neoplasm 2Myeloid 2Gynecologic 1CNS 1

Conditions

Multiple Myeloma 20Lymphoma 5Neoplasms, Plasma Cell 4Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Hodgkin Disease 2Smoldering Multiple Myeloma 1Sarcoma 1Paraproteinemias 1Neoplasm, Residual 1Myelodysplastic Syndromes 1Monoclonal Gammopathy of Undetermined Significance 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Leukemia, Myeloid, Acute 1Immunoglobulin Light-chain Amyloidosis 1Immunoblastic Lymphadenopathy 1Hematologic Neoplasms 1Disease 1Carcinoma 1Amyloidosis 1Alzheimer Disease 1

Interventions

Cyclophosphamide 71fludarabine phosphate 67Peripheral Blood Stem Cell Transplantation 60Mycophenolic Acid 52Whole-Body Irradiation 42Cyclosporine 39Tacrolimus 38Busulfan 35Antilymphocyte Serum 35Filgrastim 29Radiotherapy 27Methotrexate 24Melphalan 20Cord Blood Stem Cell Transplantation 19Methylprednisolone 17Etoposide 15fludarabine 11Therapeutics 10Flow Cytometry 10Sirolimus 9Psychiatric Rehabilitation 8Granulocyte Colony-Stimulating Factor 8Cytarabine 8sargramostim 7Rituximab 7Polymerase Chain Reaction 7Bortezomib 7Transplantation 6Alemtuzumab 6Thiotepa 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lymphoma, Follicular × Blood Specimen Collection × Plasma cell × Clear all
NCT05735704 2025-03-26

SANGUINE

JaxBio Ltd

Unknown
3,000 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms

NCT00569309 2018-03-12

Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma

Ohio State University Comprehensive Cancer Center

Phase NA Completed
30 enrolled 8 charts
LymphoidPlasma cell

Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡